| Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression IO Potapenko, VD Haakensen, T Lüders, Å Helland, I Bukholm, T Sørlie, ... Molecular oncology 4 (2), 98-118, 2010 | 218 | 2010 |
| Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis T Fleischer, A Frigessi, KC Johnson, H Edvardsen, N Touleimat, J Klajic, ... Genome biology 15, 1-13, 2014 | 216 | 2014 |
| Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling VN Kristensen, CJ Vaske, J Ursini-Siegel, P Van Loo, SH Nordgard, ... Proceedings of the National Academy of Sciences 109 (8), 2802-2807, 2012 | 204 | 2012 |
| Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC R Saldova, A Asadi Shehni, VD Haakensen, I Steinfeld, M Hilliard, I Kifer, ... Journal of proteome research 13 (5), 2314-2327, 2014 | 168 | 2014 |
| Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ... Nature genetics 48 (4), 374-386, 2016 | 160 | 2016 |
| Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from … N Girard, J Bar, P Garrido, MC Garassino, F McDonald, F Mornex, ... Journal of Thoracic Oncology 18 (2), 181-193, 2023 | 117 | 2023 |
| Molecular profiling of human mammary gland links breast cancer risk to a p27+ cell population with progenitor characteristics S Choudhury, V Almendro, VF Merino, Z Wu, R Maruyama, Y Su, ... Cell stem cell 13 (1), 117-130, 2013 | 110 | 2013 |
| Glycan-related gene expression signatures in breast cancer subtypes; relation to survival IO Potapenko, T Lüders, HG Russnes, Å Helland, T Sørlie, VN Kristensen, ... Molecular oncology 9 (4), 861-876, 2015 | 92 | 2015 |
| Subtype‐specific micro‐RNA expression signatures in breast cancer progression VD Haakensen, V Nygaard, L Greger, MR Aure, B Fromm, IRK Bukholm, ... International journal of cancer 139 (5), 1117-1128, 2016 | 69 | 2016 |
| Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms J Lehtiö, T Arslan, I Siavelis, Y Pan, F Socciarelli, O Berkovska, HM Umer, ... Nature cancer 2 (11), 1224-1242, 2021 | 63 | 2021 |
| Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics JA Espinoza, S Jabeen, R Batra, E Papaleo, V Haakensen, ... Oncoimmunology 5 (12), e1248015, 2016 | 63 | 2016 |
| Profiling of micro RNA s in tumor interstitial fluid of breast tumors–a novel resource to identify biomarkers for prognostic classification and detection of cancer AR Halvorsen, Å Helland, P Gromov, VT Wielenga, MLM Talman, ... Molecular oncology 11 (2), 220-234, 2017 | 62 | 2017 |
| Breast cancer polygenic risk score and contralateral breast cancer risk I Kramer, MJ Hooning, N Mavaddat, M Hauptmann, R Keeman, ... The American Journal of Human Genetics 107 (5), 837-848, 2020 | 58 | 2020 |
| Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density VD Haakensen, M Biong, OC Lingjærde, MM Holmen, JO Frantzen, ... Breast cancer research 12, 1-11, 2010 | 57 | 2010 |
| Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity R Dannenfelser, M Nome, A Tahiri, J Ursini-Siegel, HKM Vollan, ... Oncotarget 8 (34), 57121, 2017 | 52 | 2017 |
| Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas VD Haakensen, T Bjøro, T Lüders, M Riis, IK Bukholm, VN Kristensen, ... BMC cancer 11, 1-11, 2011 | 52 | 2011 |
| Non‐small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease HA Eide, AR Halvorsen, V Sandhu, A Fåne, J Berg, VD Haakensen, ... Clinical & Translational Immunology 5 (11), e109, 2016 | 47 | 2016 |
| Serum N-glycan analysis in breast cancer patients–relation to tumour biology and clinical outcome VD Haakensen, I Steinfeld, R Saldova, AA Shehni, I Kifer, B Naume, ... Molecular oncology 10 (1), 59-72, 2016 | 47 | 2016 |
| Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features VD Haakensen, OC Lingjærde, T Lüders, M Riis, A Prat, MA Troester, ... BMC medical genomics 4, 1-12, 2011 | 46 | 2011 |
| Polymorphisms in a putative enhancer at the 10q21. 2 breast cancer risk locus regulate NRBF2 expression H Darabi, K McCue, J Beesley, K Michailidou, S Nord, S Kar, ... The American Journal of Human Genetics 97 (1), 22-34, 2015 | 45 | 2015 |
